Page 216 - Read Online
P. 216

Page 10 of 10                                                   Sticchi et al. Vessel Plus 2018;2:23  I  http://dx.doi.org/10.20517/2574-1209.2018.47

                   Cardiovasc Interv 2012;5:477-86.
               30.  Azmoun A, Amabile N, Ramadan R, Ghostine S, Caussin C, Fradi S, Raoux F, Brenot P, Nottin R, Deleuze P. Transcatheter aortic valve
                   implantation through carotid artery access under local anaesthesia. Eur J Cardiothorac Surg 2014;46:693-8.
               31.  Guyton RA, Block PC, Thourani VH, Lerakis S, Babaliaros V. Carotid artery access for transcatheter aortic valve replacement. Catheter
                   Cardiovasc Interv 2013;82:E583-6.
               32.  Modine T, Sudre A, Delhaye C, Fayad G, Lemesle G, Collet F, Koussa M. Transcutaneous aortic valve implantation using the left ca-
                   rotid access: feasibility and early clinical outcomes. Ann Thorac Surg 2012;93:1489-94.
               33.  Halabi M, Ratnayaka K, Faranesh AZ, Chen MY, Schenke WH, Lederman RJ. Aortic access from the vena cava for large caliber trans-
                   catheter cardiovascular interventions: pre-clinical validation. J Am Coll Cardiol 2013;61:1745-6.
               34.  Greenbaum AB, O’Neill WW, Paone G, Guerrero ME, Wyman JF, Cooper RL, Lederman RJ. Caval-aortic access to allow transcatheter
                   aortic valve replacement in otherwise ineligible patients: initial human experience. J Am Coll Cardiol 2014;63:2795-804.
               35.  Pascual I, Carro A, Avanzas P, Hernández-Vaquero D, Díaz R, Rozado J, Lorca R, Martín M, Silva J, Morís C. Vascular approaches for
                   transcatheter aortic valve implantation. J Thorac Dis 2017;9:S478-87.
               36.  Lederman RJ, Babaliaros VC, Greenbaum AB. How to perform transcaval access and closure for transcatheter aortic valve implanta-
                   tion. Catheter Cardiovasc Interv 2015;86:1242-54.
               37.  Ruparelia N, Latib A, Buzzatti N, Giannini F, Figini F, Mangieri A, Regazzoli D, Stella S, Sticchi A, Kawamoto H, Tanaka A, Agricola E,
                   Monaco F, Castiglioni A, Ancona M, Cioni M, Spagnolo P, Chieffo A, Montorfano M, Alfieri O, Colombo A. Long-term outcomes after
                   transcatheter aortic valve implantation from a single high-volume center (The Milan Experience). Am J Cardiol 2016;117:813-9.
               38.  Ciuca C, Tarantini G, Latib A, Gasparetto V, Savini C, Di Eusanio M, Napodano M, Maisano F, Gerosa G, Sticchi A, Marzocchi A, Al-
                   fieri O, Colombo A, Saia F. Trans-subclavian versus transapical access for transcatheter aortic valve implantation: a multicenter study.
                   Catheter Cardiovasc Interv 2016;87:332-8.
               39.  Garcia DC, Benjo A, Cardoso RN, Macedo FY, Chavez P, Aziz EF, Herzog E, Alam M, de Marchena E. Device stratified comparison
                   among transfemoral, transapical and transubclavian access for transcatheter aortic valve replacement (TAVR): a meta-analysis. Int J
                   Cardiol 2014;172:e318-21.
               40.  Chandrasekhar J, Hibbert B, Ruel M, Lam BK, Labinaz M, Glover C. Transfemoral vs non-transfemoral access for transcatheter aortic
                   valve implantation: a systematic review and meta-analysis. Can J Cardiol 2015;31:1427-38.
               41.  Shults C, Gunter R, Thourani VH. The versatility of transapical access: will it lead to a completely new approach to valvular therapy?
                   Ann Cardiothorac Surg 2012;1:220-3.
               42.  Stortecky S, Buellesfeld L, Wenaweser P, Windecker S. Transcatheter aortic valve implantation: the procedure. Heart 2012;98:iv44-51.
               43.  Généreux P, Webb JG, Svensson LG, Kodali SK, Satler LF, Fearon WF, Davidson CJ, Eisenhauer AC, Makkar RR, Bergman GW,
                   Babaliaros V, Bavaria JE, Velazquez OC, Williams MR, Hueter I, Xu K, Leon MB; PARTNER Trial Investigators. Vascular complica-
                   tions after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am
                   Coll Cardiol 2012;60:1043-52.
               44.  Hayashida K, Lefèvre T, Chevalier B, Hovasse T, Romano M, Garot P, Mylotte D, Uribe J, Farge A, Donzeau-Gouge P, Bouvier E,
                   Cormier B, Morice MC. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv
                   2011;4:851-8.
               45.  Reidy C, Sophocles A, Ramakrishna H, Ghadimi K, Patel PA, Augoustides JG. Challenges after the first decade of transcatheter aortic
                   valve replacement: focus on vascular complications, stroke, and paravalvular leak. J Cardiothorac Vasc Anesth 2013;27:184-9.
               46.  Toggweiler S, Gurvitch R, Leipsic J, Wood DA, Willson AB, Binder RK, Cheung A, Ye J, Webb JG. Percutaneous aortic valve replace-
                   ment: vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol 2012;59:113-8.
               47.  Di Mario C, Eltchaninoff H, Moat N, Goicolea J, Ussia GP, Kala P, Wenaweser P, Zembala M, Nickenig G, Alegria Barrero E, Snow T,
                   Iung B, Zamorano P, Schuler G, Corti R, Alfieri O, Prendergast B, Ludman P, Windecker S, Sabate M, Gilard M, Witowski A, Danen-
                   berg H, Schroeder E, Romeo F, Macaya C, Derumeaux G, Maggioni A, Tavazzi L; Transcatheter Valve Treatment Sentinel Registry
                   (TCVT) Investigators of the EURObservational Research Programme (EORP) of the European Society of Cardiology. The 2011-12
                   pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients. EuroIntervention
                   2013;8:1362-71.
               48.  Van Mieghem NM, Tchetche D, Chieffo A, Dumonteil N, Messika-Zeitoun D, van der Boon RM, Vahdat O, Buchanan GL, Marcheix B,
                   Himbert D, Serruys PW, Fajadet J, Colombo A, Carrié D, Vahanian A, de Jaegere PP. Incidence, predictors, and implications of access
                   site complications with transfemoral transcatheter aortic valve implantation. Am J Cardiol 2012;110:1361-7.
               49.  Mussardo M, Latib A, Chieffo A, Godino C, Ielasi A, Cioni M, Takagi K, Davidavicius G, Montorfano M, Maisano F, Carlino M, Fran-
                   co A, Covello RD, Spagnolo P, Grimaldi A, Alfieri O, Colombo A. Periprocedural and short-term outcomes of transfemoral transcatheter
                   aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve. JACC Cardiovasc Interv 2011;4:743-50.
               50.  De Backer O, Arnous S, Sandholt B, Brooks M, Biasco L, Franzen O, Lönn L, Bech B, Søndergaard L. Safety and efficacy of using the
                   Viabahn endoprosthesis for percutaneous treatment of vascular access complications after transfemoral aortic valve implantation. Am J
                   Cardiol 2015;115:1123-9.
               51.   Starnes BW, Arthurs ZM. Endovascular management of vascular trauma. Perspect Vasc Surg Endovasc Ther 2006;18:114-29.
   211   212   213   214   215   216   217   218   219   220   221